drugset / Trial / NCT01878227
Comparison of Coenzyme A and Fenofibrate for Safety and Efficacy On Patients With Hyperlipidemia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to compare the lipid lowering effects and clinical safety of a natural hypolipidemic compound, coenzyme A capsule with a marketed drug, fenofibrate, in Chinese patients with moderate dyslipidemia.
Timeline
- Start
- 2010-07
- Primary completion
- 2011-05
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Coenzyme A | Small molecule | 400 mg | Oral |
| Comparator | Fenofibrate | Small molecule | 200 mg | — |